These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8791971)

  • 1. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
    Scarpignato C; Kisfalvi I; D'Amato M; Varga G
    Aliment Pharmacol Ther; 1996 Jun; 10(3):411-9. PubMed ID: 8791971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
    Varga G; Kisfalvi K; D'Amato M; Scarpignato C
    J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
    Varga G; Scarpignato C
    Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
    Corwin RL; Smith GP
    Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
    Bertrand P; Böhme GA; Durieux C; Guyon C; Capet M; Jeantaud B; Boudeau P; Ducos B; Pendley CE; Martin GE
    Eur J Pharmacol; 1994 Sep; 262(3):233-45. PubMed ID: 7813588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of KSG-504, a new CCK-A receptor antagonist, on gallbladder and gastrointestinal functions].
    Yamazaki Y; Akahane M; Kobayashi M; Shinagawa K; Sugiura M; Ajisawa Y
    Nihon Yakurigaku Zasshi; 1996 Jan; 107(1):33-44. PubMed ID: 8720296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.
    Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):406-13. PubMed ID: 12690433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity and potency of new basic CCK-B antagonists.
    Rovati LC; D'Amato M; Peris W; Revel L; Makovec F
    Ann N Y Acad Sci; 1994 Mar; 713():395-7. PubMed ID: 8185200
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function.
    Tachibana I; Kanagawa K; Yamamoto Y; Otsuki M
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1404-12. PubMed ID: 8968365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
    Yuki H; Nishida A; Miyake A; Ito H; Akuzawa S; Takinami Y; Takemoto Y; Miyata K
    Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives.
    Makovec F; Peris W; Revel L; Giovanetti R; Mennuni L; Rovati LC
    J Med Chem; 1992 Jan; 35(1):28-38. PubMed ID: 1732532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-antigastrin activity relationships of new spiroglumide amido acid derivatives.
    Makovec F; Peris W; Frigerio S; Giovanetti R; Letari O; Mennuni L; Revel L
    J Med Chem; 1996 Jan; 39(1):135-42. PubMed ID: 8568800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function.
    Varga G; Kordás K; Burghardt B; Gacsályi I; Szénási G
    Eur J Pharmacol; 1999 Feb; 367(2-3):315-23. PubMed ID: 10079007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
    Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
    Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
    Taniguchi H; Yazaki N; Yomota E; Shikano T; Endo T; Nagasaki M
    Eur J Pharmacol; 1996 Sep; 312(2):227-33. PubMed ID: 8894600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCK/gastrin antagonists--clinical perspectives.
    Calam J
    Acta Gastroenterol Belg; 1993; 56(3-4):251-6. PubMed ID: 8266765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by estradiol in ovariectomized rats.
    Wu CL; Hung CR; Chang FY; Pau KY; Wang PS
    Scand J Gastroenterol; 2002 Oct; 37(10):1133-9. PubMed ID: 12408516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.